Universal Immunization Program is a vaccination program launched by the Government of India in 1985.
It became a part of Child Survival and Safe Motherhood Program in 1992 and is currently one of the key areas under National Rural Health Mission(NRHM) since 2005.
Program consists of vaccination for 12 diseases -
Tuberculosis
Diphtheria
Pertussis
Tetanus,
Poliomyelitis,
Measles,
Hepatitis B,
Diarrhea,
Japanese-Encephalitis,
Rubella,
Pneumonia
Pneumococcal diseases
Universal Immunization Programme (UIP), started in India in 1985.
Ministry of Health & Family Welfare provides several vaccines to infants, children & pregnant women through UIP.
Immunization is a process through which a person is made immune to an infectious disease.
National leprosy eradication program CHNNehaNupur8
Leprosy is a chronic infectious disease caused by ‘Mycobacterium Leprae’ an acid fast , rod shaped bacillus.
The disease mainly affects the skin , the peripheral nerves , mucosa of the upper respiratory tract and also eyes.
Cardinal Features:-
° Hypopigmented patch
° Loss of cutaneous sensation
° Thickened Nerve
° Acid fast bacilli
Leprosy has been regarded by tbe community as a contagious , mutilating and incurable disease.
Leprosy is curable and treatment provided in the early stages averts disability.
Multidrug Therapy (MDT) treatment has been made available by WHO free of charge to all patients worldwide since 1995, and provides a simple yet highly effective cure for all typesof leprosy.
Universal Immunization Programme (UIP), started in India in 1985.
Ministry of Health & Family Welfare provides several vaccines to infants, children & pregnant women through UIP.
Immunization is a process through which a person is made immune to an infectious disease.
National leprosy eradication program CHNNehaNupur8
Leprosy is a chronic infectious disease caused by ‘Mycobacterium Leprae’ an acid fast , rod shaped bacillus.
The disease mainly affects the skin , the peripheral nerves , mucosa of the upper respiratory tract and also eyes.
Cardinal Features:-
° Hypopigmented patch
° Loss of cutaneous sensation
° Thickened Nerve
° Acid fast bacilli
Leprosy has been regarded by tbe community as a contagious , mutilating and incurable disease.
Leprosy is curable and treatment provided in the early stages averts disability.
Multidrug Therapy (MDT) treatment has been made available by WHO free of charge to all patients worldwide since 1995, and provides a simple yet highly effective cure for all typesof leprosy.
Polio is a viral disease that destroys the nerve cells present in the spinal cord causing paralysis or muscle weakness to some part of the body.
Pulse Polio Programme was launched in 1995 after a resolution for a global initiative of polio eradication was adopted by World Health Assembly (WHA) in 1988.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
Polio is a viral disease that destroys the nerve cells present in the spinal cord causing paralysis or muscle weakness to some part of the body.
Pulse Polio Programme was launched in 1995 after a resolution for a global initiative of polio eradication was adopted by World Health Assembly (WHA) in 1988.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
On 19 November 1985, GOI renamed EPI program, modifying the schedule as ‘Universal Immunization Program’ dedicated to the memory of Late Prime Minister Mrs Indira Gandhi.
UIP has two vital components: immunization of pregnant women against tetanus, and immunization of children
National Leprosy Eradication Programme (NLEP)Kavya .
Chronic infectious disease caused by Mycobacterium leprae.
It usually affects the skin and peripheral nerves
Long incubation period generally 5-7 years.
Classified as paucibacillary or multibacillary
permanent disability
Timely diagnosis and treatment of cases
Pulse Polio is an immunisation campaign established by the government of India to eliminate poliomyelitis (polio) in India by vaccinating all children under the age of five years against the polio virus.
Acquired immunodeficiency syndrome (AIDS) is a chronic, potentially life-threatening condition caused by the human immunodeficiency virus (HIV). By damaging your immune system, HIV interferes with your body's ability to fight infection and disease.
The National AIDS Control Programme (NACP), launched in 1992, is being implemented as a comprehensive programme for prevention and control of HIV/AIDS in India. Over time, the focus has shifted from raising awareness to behavior change, from a national response to a more decentralized response and to increasing involvement of NGOs and networks of PLHIV.
Expanded Program of Immunization.
Objectives are:
To learn about EPI and the current situation of EPI in Pakistan
To understand the mechanism of the Cold Chain and the maintenance of vaccines
1Global Vaccination (attach this please with the previou.docxfelicidaddinwoodie
1
Global Vaccination (attach this please with the previous sections)
WHO estimates that three million cases of disease could be avoided annually with an appropriate prevention by vaccination.
Immunization System in Malasyia (more info please add to US)
Religious Views of Vaccination (Malaysia)(please attach this with the previous sections)
Grabenstein (2013) noted that polio immunization is obligatory when disease risk is high and the vaccine shown to have benefits far outweighing its risks.
National Immunization Program (NIP)
The Malaysian National Immunization Program (NIP) was introduced in the early 1950s and it has been given free to the children for their protection against major childhood diseases. The immunization program offers protection against major childhood diseases that can be prevented with vaccines including diphtheria, tetanus, pertussis, Haemophilus influenzae type b, hepatitis B, measles, mumps, rubella, tuberculosis, polio and some diseases caused by the human papillomavirus. This program is available at all government clinics across the country.
Parents are responsible for ensuring that their children are protected from dangerous infectious diseases that can be prevented with a vaccine. Below is the national immunization schedule to ensure your child receives the vaccination at the right time (Malaysian MOH, 2017).
Vaccine Safety Surveillance
National Centre of Adverse Drug Reactions (ADR) Monitoring, National Pharmaceutical Control Bureau (NPCB) is responsible to monitor the safety of medicines and vaccines that are registered in Malaysia. NPCB is responsible for collecting all reporting adverse events related pharmaceutical products including vaccines. All reported adverse events will be documented and serious cases following vaccination will be investigated promptly to identify the cause of the adverse events. NPCB will make further investigation in terms of product quality and regulatory action will be taken based on the results of the investigation. Types of regulatory action that can be taken are the suspension of the product registration, product recall or cancellation of the product registration.
ADR reporting system has been introduced in Malaysia to enable health providers to participate in monitoring the safety of medicines and vaccines by reporting the adverse events. Ministry of Health Malaysia (MOH) has organized trainings to the health professionals on the importance of reporting of Adverse events following immunization (AEFIs) as described in the Guidelines for the Pharmacovigilance of Vaccines. Ongoing training will be conducted more actively to increase awareness among health care providers to report AEFI and importance of disseminating the information to parents/guardians.
Currently, the AEFI reporting system has been extended to the public whereby the parents/guardians of children who experience any adverse events can report to us by themselves (Malaysian MOH, 2017).
Immunization System in the US ...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
1. PRESENTED BY : N/CDT. PRIYANKA GIRI
IV YEAR BASIC B.SC NURSING
GUIDED BY : LT. COL. MEENAKSHI MANOCHA
ASSOCIATE PROFESSOR
2. Universal Immunization Program is
a vaccination program launched by
the Government of India in 1985.
It became a part of Child Survival and Safe
Motherhood Program in 1992 and is currently
one of the key areas under National Rural
Health Mission(NRHM) since 2005.
5. UNDER RCH I
The most common constraints of immunization
success are
- Non uniform coverage
- Poor implementation
- Poor monitoring
- High dropouts
- Over reporting
- Poor injection safety
6. - Reorientation of staff being not carried out
- Cold chain replacement plan not made
- Vacancy of staff at field level not filled
- Poor surveillance of vaccine preventable dieses
- Poor vaccine logistics
- Poor maintenance of equipment
- Extra ordinary emphasis on polio vaccine
7. Under RCH II
The six goals and their respective objectives
with strategies to achieve these objectives are
summaries in following slides.
8. Districts will provide efficient and safe
immunization to all infants and pregnant women.
Objectives
Regular quality immunization sessions are
planned and held.
Adequate trained staff are empowered to
provide quality immunization services.
9. An annually upgraded cold chain inventory
according to level of network, in order to
maintain a functional status of 90%.
An efficient vaccine and injection equipment
management and logistic system to forecast and
deliver adequate supplies of vaccines in timely
manner.
The implementation of safe injection practices
and waste disposal.
10. Strategies
Strategies include coordination between national
and state level.
Printing and supply of national operation
guideline.
Strengthening of supervision.
Prioritization of under served population within
districts.
Strengthening & training of all categories of staff.
11. Management of cold chain.
Procurement installation of cold chain
equipment.
Proper inventory management.
Cold chain maintenance and repair.
Timely supply of vaccine.
Phased introduction of auto disposal syringes
and safety boxes.
12. Contribute to global polio eradication, measles
mortality reduction and neonatal tetanus
elimination.
Objectives
Polio eradication certification by 2007.
Elimination of neonatal tetanus by 2009.
Reduction measles mortality by 2/3 compared to
2000 estimates, by 2010.
Achieve and maintain 70% coverage of two
doses of vitamin A to children < 3 years.
13. Strategies
Strategies include routine immunization for
polio.
Supplementary immunization campaigns.
AFP virological surveillance.
Strengthening service delivery.
Increasing reporting and action on cases.
Data analysis.
Safe delivery practices.
Targeting supplementary immunization activities.
Strengthening measles vaccination and
surveillance and response to the outbreaks.
14. The UIP will have sufficient and sustainable
funding with established adequate, accountable
and efficient fund flows.
Objectives
Adequate and reliable financial resources and
national, state and local levels for UIP to achieve
goals and objectives.
Political commitments for adequate annual
funding at all levels.
Strategies
Strengthening national financial planning and
building partnerships.
15. Sustain demand and reduce social barriers to
access immunization services.
Objectives
Widespread support by families & communities.
All eligible children and pregnant women are
immunized.
High level political and administrative support for
immunization.
Strategies
Include coverage with print, electronic media
and improve interpersonal communication.
16. Accelerated introduction of licensed new and
under utilized vaccines against diseases with
significant mortality and morbidity in India.
Objectives
Institutional mechanisms in place to adequately
obtained, review and utilize information for
deciding on introduction of new and under
utilized vaccines.
Review need for MMR or MR vaccine in India’s
immunization program.
17. Review need for introduction of Japanese
encephalitis vaccine.
A phased introduction of Hepatitis B vaccine.
Strategies
Strategies include improve coordination
between MoHFW, research institute, NRI and
development partners, disease burden study,
surveillance and training.
18. To monitor and use accurate, complete and
timely data on vaccine preventable disease,
AEFIs, antigen coverage and drop out rates by
districts.
Objectives
Institutionalize surveillance of VPD’s and early
detection of any outbreaks.
19. Strengthened vaccine quality and injection
safety by developing monitoring system.
An effective, efficient, complete and timely
immunization, local recording and area
monitoring system.
20. Measles is highly contagious viral disease,
occur in over crowded area and coverage of
measles vaccine is poor.
These areas needed special vaccination drive
which was initiated by UNICEF in 1998 covering
13 cities and in 1999-2000, 50 more cities were
also covered.
Now the main focus is on covering all
unprotected children upto 3 years.
Age of giving MMR vaccine is 15 months.
21. MMR can be given till 5 years of age under UIP.
Greece and Bulgaria indicates low coverage of
vaccination in children due to change in national
immunization schedule.
Study highlights that there is need of constant
supervision of national immunization program
and repeat dose of MMR in adolescents or
youth.
22.
23. In some places like Delhi the measles, mumps
and rubella (MMR) vaccine has been introduced
in the program.
It is given at 15 month of age in a dose of 0.5ml
IM/SC.
If measles is not received by the child till 12
months of age MMR vaccine can be given.
MMR can be given till 5 years of age under the
program.
24. Neonatal tetanus is a common problem in many
developing countries.
In some instances NNT is responsible for >50%
of neonatal deaths which, themselves, may
account for >50% of all infants deaths.
It is estimated that about 3,00,000 cases NNT
occurred worldwide each year, of which
approximately 2/3 died.
25. In 1990 neonatal tetanus accounted for almost
80,000 deaths. India was finally declared free of
maternal and neonatal tetanus on May 15, 2015
by WHO.
Scientifically this disease has been eliminated
by immunizing all women in reproductive age
group with tetanus toxoid.
Elimination of NNT is done by-
Coverage of all pregnant women with two doses
of tetanus toxoid
26. Extensive IEC efforts to promote clean
deliveries;
Five cleans-clean hands, clean surface, clean
blade, clean stump, clean cord tie.
Providing disposable delivery kits
Community based surveillance of neonatal
deaths and investigation and control measures
in case of neonatal deaths.
27. Neonatal tetanus elimination is defined as less
than 1 case of neonatal tetanus per 1000 live
births in every district.
Recommendation after validation of NTT
elimination;
Maintain High TT vaccination coverage to
pregnant women.
Improve institutional delivery practices
Strengthen surveillance of NNT.
28. Hepatitis B is viral infection that attacks the liver
and can cause both acute and chronic liver
disease.
The virus is transmitted through contact with
blood or other body Fluids of an infected person.
It is a major Global health problem and the most
serious type of viral hepatitis.
About 2 billion people worldwide have been
infected with virus and about 350 million live
with chronic infection.
29.
30. An estimated 6 lakh persons die each year due
to acute or chronic consequences of Hepatitis B.
The Hepatitis virus is 50 to 100 times more
infectious than HIV.
Hepatitis B virus is an important occupational
hazard for health workers.
India is in an intermediate endemic state with
prevalence of 2-7 %.
Hepatitis B is preventable with a safe and
effective vaccine. A vaccine against Hepatitis B
have been available since 1982. Hepatitis B
vaccine is 95 % effective in preventing HBV
infection and its chronic consequences.
31. First dose of hepatitis B may be given at birth or
within 48 hours of delivery in institutional
deliveries. Otherwise three doses are given
together with OPV and DPT doses in the dose of
0.5 ml intramuscularly.
32. Typhoid is a major public health problem in
India.
Causes heavy morbidity and mortality.
Typhoid vaccine has been introduced in Delhi by
the Directorate of safeguards all children below
5 years of age.
Vaccine can be given to the children above 2
years of age till 5 years of age IM.
33. Approximately 410000 of under 5 deaths in India
are due to pneumonia out of which an estimated
70000 are caused by Haemophilus Influenzae
Type B.
Data from some developing countries such as
Bangladesh, Chile and Malawi suggested that it
is a cause of over 20% of life threatening
childhood pneumonia.
Small scale studies from India have documented
case fatality rate of HIB Meningitis as 11 %, and
about 30% of survivors suffer from major
disabilities.
34.
35. This is why HIB vaccine introduction in National
immunization Program (NIP) of India has been
done.
The Pentavalent vaccine combines 5 different
vaccine in one injection to protect at least five
diseases;
I. Haemophilus Influenzae Type B diseases
II. Diphtheria
III. Pertussis
IV. Tetanus
V. Hepatitis B.
36. Children immunized with the 5-in-1 vaccine don’t
need to be vaccinated separately with the DPT
or Hepatitis B vaccine
All children during their first year of age should
receive 3 doses of pentavalent vaccine with an
interval of at least 4 weeks between the doses.
However children who have already started
immunization with DPT and hepatitis B have to
complete their vaccination with DPT and
hepatitis B only, they are not to be given
pentavalent vaccine.
37. Vaccination with pentavalent must be completed
within 2 years of age if the child starts before
one year of age.
Children under 6 weeks of age, over 5 years,
teenagers and adults should not be given
pentavalent vaccine because of the DPT
component.
38. The "cold-chain" is a system of storage and
transport of vaccine at low temperature from the
manufacturer to the actual vaccination site.
In other words the success of national
immunization program is highly dependant on
supply chain system for delivery of vaccines and
equipments, with a functional system that meets
6 rights of supply chain;
-The right vaccine in right quantity at the right
place at the right time in the right condition
and at the right cost.
39. Among the vaccines, Polio is the most sensitive
to heat requiring storage at -20 degree
centigrade.
Vaccines must be stored in the freezer
compartment are; Polio and Measles.
Vaccine which must be stored in cold part but
never allowed to freeze are "T Series" vaccines
(DPT, Tetanus toxoid, DT) Hepatitis B, BCG and
Diluents.
40. In general all vaccine must be stored under the
conditions recommended by the manufacturer in
the literature accompanying the vaccine,
otherwise they may become denatured and
totally ineffective.
Vaccine must be protected from sunlight and
antiseptics.
At the health centre, most vaccines can be
stored up to 5 weeks if the refrigerator
temperature is strictly kept between 2 to 8
centigrade.
41. Do not keep any used vials in the cold chain.
Return the unused vaccine vial from the session
site to the PHC on the same day in the cold
chain through alternative vaccine delivery.
Keep the box labeled "returned unused" in the
ILR for all unused vaccines that can be used in
the subsequent session, but discard vaccines
that have been returned unopened more than 3
times.
42. Walk in cold room (WIC): located at regional
level. Store vaccine for 3 months. Serve 4 to 5
districts.
43. Deep freezer: supplied to all districts (large) and PHC
(small) to store vaccines.
Temperature maintain between -15 degree centigrade to
-25 degree centigrade.
In case of power failure these freezers can maintain the
cabinet temperature for 18 to 22 hours.
44. Ice Lined Refrigerator (ILR) : ILR are kept at
the PHC (small) and District level (large).
The cabinet temperature is maintained at + 2
degree centigrade to + 8 degree centigrade. At
the PHC level, ILR are used for storing all UIP
vaccine. ILR are lined with tubes or Ice packs
filled with water which freezes and keeps the
internal temperature at a safe level.
All vaccines must be kept in the basket of the
ILR along with the diluents.
45. A Dial thermometer should be kept in the ILR
and temperature recorded twice a day. At the
time of defrosting the vaccines are shifted to the
cold boxes containing required number of frozen
ice packs.
46. COLD BOXES: Cold boxes are supplied to all
peripheral centres.
These are used mainly for transportation of the vaccines.
47. Before the vaccines are place in the cold boxes,
fully frozen ice packs are placed at the bottom
and sides.
The vaccines are first kept in cartons or
Polythene bags.
The vials of DPT, DT, TT vaccines and diluents
should not be placed in direct contact with the
frozen ice packs.
48. Vaccine Carrier: Vaccine Carriers are used to
carry small quantities of vaccines (16 to 20 vials)
for the out of reach session.
4 fully frozen ice packs are used for lining the
sides, and the vials of DPT, DT, TT and diluents
should not be placed in direct contact with the
frozen ice packs.
The carriers should be closed tightly.
49. Day Carriers: Day Carriers are used to carry
small quantities of vaccines (6 to 8) vials to a
nearby session.
It is only used for few hours period.
50. Ice Packs: The ice pack contain water and no salt
should be added to it.
The water should be filled up to the level mark on the
side.
If there is any leakage such ice pack should be
discarded.
51.
52. The shake test to determine whether vaccine
has been frozen
DPT, hepatitis B and Tetanus toxoid vaccines
can be damaged by freezing. You can find out
whether this has occurred by using the shake
test.
1. Take two DPT vials, one that you think might
have been frozen and another from the same
manufacturer which you KNOW has never
been frozen.
53. 2. Shake both vials.
3. Look at the vaccine inside the two vials.
4. Let the sediment settle for 15-30 minutes.
5. Again look at the vaccine inside the two vials.
(see image)
54.
55.
56. Vaccines are not stored at the sub-centre level
and must be supplied on the day of use.
PHC must not hold more than 1 month's stock.
Immunization must be carried out in a shade.
The vaccines (OPV and Measles) must be kept
on an ice pack or in a cup of ice during the
vaccination session.
No direct sunlight should fall on them.
57. OPV sample should be sent with fully frozen ice
packs and rush to the assign laboratory for the
potency test.
Measles vaccine should be used within 4 hours
of reconstitution. Similarly BCG should not be
used after 3 hours of reconstitution.
58. Good disease surveillance.
No pathogen variations.
Potent vaccine.
Adequate development and/or procurement of
vaccines.
Appropriate and acceptable choice of
Technologies.
Universal vaccination (even among childhood
vaccines).
Adequate logistics, cost benefit analyses and
resource mobilization.
59. Immunization sessions are not being held
regularly in the community.
Inadequate mobility of the health worker and the
supervisory staff at district and state level.
Problem of delivery of vaccines and drugs to
outreach session's site.
In urban areas lack of adequate health
infrastructure.
Lack of trained manpower for vaccination.
Impact of rumors of vaccine adverse events or
deaths.
60. Pulse Polio is an immunization campaign
established by the government of India to
eliminate poliomyelitis (polio) in India by
vaccinating all children under the age of five
years against the polio virus. The project fights
poliomyelitis through a large-scale pulse
vaccination program and monitoring for polio
cases.
61. In India, vaccination against polio started in
1978 with Expanded Program on Immunization
(EPI). By 1984, it covered around 40% of
infants, giving three doses of OPV to each.
In 1985, the UIP was launched to cover all the
districts of the country. UIP became a part of
child survival and safe motherhood program
(CSSM) in 1992 and Reproductive and Child
Health Program (RCH) in 1997. This program
led to a significant increase in coverage, up to
95%.
62. In 1995, following the Global Polio Eradication
Initiative of the World Health Organization
(1988), India launched Pulse Polio immunization
program with Universal Immunization Program
which aimed at 100% coverage.
63. Routine immunization : Immunize every child
age <1 year with at least 4 doses of
OPV through UIP.
National immunization days (NIDs)/Pulse Polio
Immunization (PPI) program/Sub-National
Immunization days(SNIDs) : Conducted by
giving additional doses of OPV, 4 to 6 weeks
apart to every child age less than 5 years.
Intensification of the pulse polio immunization
program has been done by adding additional
rounds at fixed booths followed by house to
house "search and vaccinate" component.
64. National immunization day: In India transmission
of polio has been fluctuating so it has been
decided that there is a need to make extra
efforts to reach the unreached during pulse polio
immunization days. for that reason intensified
pulse polio immunization was proposed and just
after the national immunization day (Polio
Ravivaar ).
Immunization team would visit house to house
with a vaccine to check whether the child has
received pulse polio vaccine and if not then child
must be given a dose of that time only.
65. Surveillance of acute flaccid paralysis AFP: to
identify all reservoirs of wild polio virus
transmission surveillance of AFP has been
started. AFP is now defined as "any child is less
than 15 years of age who have sudden onset of
flaccid paralysis or paralytic illness in a person of
any age when polio suspected."
66. Setting up of booths in all parts of the country.
Initializing walk-in cold rooms, freezer rooms,
deep freezers, ice-lined refrigerators and cold
boxes for a steady supply of vaccine to booths.
Arranging employees, volunteers, and vaccines.
Ensuring vaccine vial monitor on each
vaccine vial.
67. Immunizing children with OPV on national
immunization days.
Identifying missing children from immunization
process.
Surveillance of efficacy.
Publicity was extensive and included replacing
the national telecoms' authority ringtone with a
vaccination day awareness message, posters,
TV and cinema spots, parades, rallies, and one-
to-one communication from volunteers.
Vaccination booths were set up, with a house-to-
house campaign for remote communities.